United States · Who invested in Raze Therapeutics?
Raze Therapeutics's investors include Atlas Venture, M Ventures, MPM Capital, Novartis and Astellas Venture Management, and 2 more on record.
United States · Series A startup
Who invested in Raze Therapeutics
One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$24Mraised across 1 round since 2014, from 1 source
- Latest round
- Series A, $24MOct 2014
- Investors
- 7
The rounds
- Oct 2014Series A$24M
Atlas Venture
M Ventures
MPM Capital
Novartis
Astellas Venture Management- Partners HealthCare Innovation
- MS Ventures
From a historical funding record
Everyone who backed them
Partners HealthCare InnovationCorporate VC1round
MS VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Raze Therapeutics
How much has Raze Therapeutics raised?
Raze Therapeutics has raised $24M across 1 round since 2014.
When did Raze Therapeutics last raise?
Raze Therapeutics's most recent round was a Series A of $24M in Oct 2014.
What was Raze Therapeutics's biggest round?
Its most recent round, $24M in Oct 2014, is also its largest on record.
Who backed Raze Therapeutics first?
Raze Therapeutics's first round on record, in Oct 2014, was backed by Atlas Venture, M Ventures and MPM Capital and 4 others.
What stage is Raze Therapeutics at?
Raze Therapeutics's latest named round is a Series A, in Oct 2014.
Where is Raze Therapeutics based?
Raze Therapeutics is based in the United States.
Companies like Raze Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.